{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03682",
      "entity_text" : "CIMT",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03683",
      "entity_text" : "NAFLD",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "We and others have reported that NAFLD is associated with an increased risk of impaired FMD and increased CIMT and arterial stiffness, independently of traditional risk factors and metabolic syndrome [XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-08-08T11:59:50Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T11:57:24Z",
  "trigger" : "increased",
  "evidence" : [ "NAFLD is associated with an increased risk of impaired FMD and increased CIMT" ],
  "pmc_id" : "4779836",
  "score" : 0
}